Novo Nordisk A/S - The final phase 3a trial for IDegLira completed, and FIAsp approved for phase 3 development

 | Source: Novo Nordisk A/S Novo Nordisk A/S

Pièces jointes

Company Announcement No 83 2012
GlobeNewswire